Linghua Zheng

Linghua Zheng's research focuses on how the immune system, particularly T cells, is regulated in the context of cancer, autoimmune disease, and chronic infection. Work centers on identifying molecules that either suppress or enable immune cell activity (such as CD8, VISTA/PD-1H, LAG-3, and CD93), with implications for cancer immunotherapy and autoimmune conditions like lupus. This research could interest students wanting to study how immune checkpoint molecules control T cell behavior and how these mechanisms can be targeted for therapy.

Publication output has been modest and irregular over the last decade, with occasional gaps (e.g., 2017, 2020, 2024) interspersed with small clusters of output, averaging just over one paper per year in the most recent five-year span.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026